Suppr超能文献

连续超声乳化小梁切除术联合早期针拨复位及抗代谢药物的回顾。

Review of consecutive phacotrabeculectomies supplemented with early needle revision and antimetabolites.

作者信息

Li Gisèle, Kasner Oscar

机构信息

Department of Opthalmology, Jewish General Hospital, Montreal, Que., Canada.

出版信息

Can J Ophthalmol. 2006 Aug;41(4):457-63. doi: 10.1016/S0008-4182(06)80007-4.

Abstract

BACKGROUND

To describe the results of a novel postoperative management approach for patients undergoing combined cataract and glaucoma surgery supplemented with early needle revision and antimetabolites.

METHODS

Consecutive retrospective chart review identified 66 patients who had undergone combined cataract and glaucoma surgery with early needling and antimetabolite injections between January 2002 and May 2003; 8 patients were excluded from analysis because of missing data or inadequate follow-up time. Single-site phacotrabeculectomy was performed followed by subconjunctival antimetabolite injections of 5-fluorouracil (5-FU). Needling was performed as an office procedure if early evidence of subconjunctival scarring was observed 2-6 weeks after surgery. Additional subconjunctival 5-FU injections were administered after needling, and repeat needling was performed with 5-FU or mitomycin-C if subconjunctival scarring recurred. A complete success was defined as a reduction in intraocular pressure (IOP) to <18 mm Hg without the use of antiglaucoma medications or further surgical procedures to control IOP. The outcome was considered a qualified success when antiglaucoma medications were required to achieve the same result.

RESULTS

The mean preoperative IOP was 21.9 (SD 6.3) mm Hg, and the mean postoperative IOP at 6 months was 13.0 (SD 6.7) mm Hg. The mean number of medications was reduced from 2.9 (SD 1.3) preoperatively to 0.5 (SD 0.9) postoperatively at 6 months. Needling was performed because of early evidence of subconjunctival scarring in 34 patients. The 6-month outcomes of 37 patients (64%) were a complete success and of 47 patients (81%) were a complete or qualified success. A longer follow-up of 10-23 months was attained in 25 of the 58 patients. At latest visit, the mean postoperative IOP of this group was 13.0 (SD 5.5) mm Hg, the mean number of postoperative medications was 0.7 (SD 1), and 21 of the 25 (84%) had achieved a complete or qualified success. The most common complication for all 58 patients was an early, self-limited postoperative wound leak that was unrelated to the needling intervention and was observed in 26 patients (45%).

INTERPRETATION

Phacotrabeculectomy supplemented with early needle revision and antimetabolites may improve outcomes of combined cataract and glaucoma surgery.

摘要

背景

描述一种新型术后管理方法用于接受白内障与青光眼联合手术患者的结果,该方法辅以早期针刺修复和抗代谢药物。

方法

连续回顾性病历审查确定了2002年1月至2003年5月期间接受白内障与青光眼联合手术并早期进行针刺和抗代谢药物注射的66例患者;8例患者因数据缺失或随访时间不足被排除在分析之外。进行单切口晶状体小梁切除术,随后结膜下注射5-氟尿嘧啶(5-FU)。如果术后2至6周观察到结膜下瘢痕形成的早期迹象,则在门诊进行针刺。针刺后追加结膜下5-FU注射,如果结膜下瘢痕复发,则用5-FU或丝裂霉素-C重复针刺。完全成功定义为眼压(IOP)降低至<18 mmHg,且无需使用抗青光眼药物或进一步手术来控制眼压。当需要抗青光眼药物才能达到相同结果时,该结果被视为合格成功。

结果

术前平均眼压为21.9(标准差6.3)mmHg,术后6个月平均眼压为13.0(标准差6.7)mmHg。平均用药数量从术前的2.9(标准差1.3)减少到术后6个月的0.5(标准差0.9)。34例患者因结膜下瘢痕形成的早期迹象而进行了针刺。37例患者(64%)的6个月结果为完全成功,47例患者(8%)的结果为完全成功或合格成功。58例患者中的25例获得了10至23个月的更长随访。在最近一次随访时,该组患者术后平均眼压为13.0(标准差5.5)mmHg,术后平均用药数量为0.7(标准差1),25例患者中的21例(84%)获得了完全成功或合格成功。所有58例患者中最常见的并发症是早期、自限性的术后伤口渗漏,与针刺干预无关,并在26例患者(45%)中观察到。

解读

晶状体小梁切除术辅以早期针刺修复和抗代谢药物可能改善白内障与青光眼联合手术的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验